Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TCF7L1 intronic transcript 1 (TCF7L1-IT1) is a long non-protein-coding RNA gene located within an intron of the TCF7L1 locus. Non-coding RNAs such as TCF7L1-IT1 are transcribed but not translated into proteins, and their functional roles are often less well characterized than those of protein-coding genes. There is currently no evidence that TCF7L1-IT1 acts as a receptor, signaling molecule, or therapeutic target. Its biological and clinical relevance remains undefined, with no known disease associations, interacting drugs, or biomarker status. All current information suggests this is an "other" molecular class, with potential but undemonstrated regulatory roles[5].
None (not a known druggable target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCF7L1 intronic transcript 1 (non-protein coding) (TCF7L1-IT1).